¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Human plasma protein fraction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® protein ÇÑ±Û ´Ü¹éÁú
¼³¸í   
  Åº¼Ò, ¼ö¼Ò, »ê¼Ò, Áú¼Ò, È²À» ÇÔÀ¯Çϰí Àִ À¯±âÈ­ÇÕ¹°·Î, ¸ðµç ¼¼Æ÷ÀÇ ¿øÇüÁúÀ» ÀÌ·ç°í Àִ ±âº» ±¸¼º¹°ÁúÀÌ´Ù. ´Ü¹éÁúÀº ±× ´ÜÀ§ÀΠ¾Æ¹Ì³ë»êµéÀÌ ÆéƼµå°áÇÕ¿¡ ÀÇÇØ °áÇյǾî ÀÖÀ¸¸ç, º¸Åë 20°³ÀÇ ¾Æ¹Ì³ë»êµéÀÌ ´Ù¸¥ ¼ø¼­¿Í Á¶¼ºÀ» °¡Áö°í ¹è¿­µÇ¾î, µ¶Æ¯ÇÑ ÇϳªÀÇ ´Ü¹éÁúÀ» Çü¼ºÇϰԠµÈ´Ù.
¿µ¹® beta human chorionic gonadotropin ÇÑ±Û º£Å¸ »ç¶÷À¶¸ð¼º »ý½Ä»ùÀÚ±ØÈ£¸£¸ó
¼³¸í   
  Å¹ݼ¼Æ÷¿¡¼­ ¸¸µé¾îÁö´Â È£¸£¸ó. ±â´ÉÀº ÀÓ½ÅÀÇ Ãʱ⿡ È²Ã¼(¿ø·¡ ³­ÀÚ¸¦ ½Î°í ÀÖ´ø ¼¼Æ÷µéÀÌ ¹è¶õÀÌ ÀϾ¼­ ³­ÀÚ°¡ ºüÁ®³ª°£ ÈÄ ÁÖ¸Ó´Ï ¸ð¾çÀ» ÀÌ·é °Í. ÀÓ½ÅÃʱ⿡ ÀÓ½ÅÀÇ À¯Áö¿¡ ÇÊ¿äÇѠȣ¸£¸óÀ» »ý¼ºÇÑ´Ù)ÀÇ À¯Áö¿¡ ±â¿©Çϰí, Å¾ÆÀÇ °íȯÁ¶Á÷¿¡¼­ ³²¼ºÈ£¸£¸óÀÌ ºÐºñµÇ´Â °ÍÀ» ÃËÁø½ÃŲ´Ù. ¶Ç À̰ÍÀº ÀÓ½ÅÃʱâÀÇ ÀÓ»êºÎÀÇ ¼Òº¯¿¡¼­ ¸¹Àº ¾çÀÌ °ËÃâµÇ¹Ç·Î À̰ÍÀ» ÀÌ¿ëÇØ¼­ ÀÓ½ÅÀÇ ¿©ºÎ¸¦ ¼Õ½±°Ô Á¶»çÇÒ ¼ö°¡ ÀÖ´Ù.
¿µ¹® plasma ÇÑ±Û Ç÷Àå
¼³¸í   
  Ç÷¾×À̳ª ¸²ÇÁ¾×ÀÇ ¾×ü ºÎºÐÀ» ¸»Çϴµ¥, ÁַΠÇ÷¾×¿¡¼­ °íÇü¼ººÐ(Ç÷±¸¼¼Æ÷)À» Á¦¿ÜÇÑ ¾×ü ºÎºÐÀ» ÀǹÌÇÑ´Ù. ¿©±â¿¡´Â ´Ü¹é¼ººÐ(¸é¿ªÇö»óÀ» À¯¹ßÇϴ Ç×ü¸¦ Æ÷ÇÔÇÔ), ¿µ¾ç¼ººÐ(°¢ ¼¼Æ÷¿¡ ¿µ¾çºÐÀ» °ø±ÞÇÔ), ±×¸®°í Ç÷¾×ÀÀ°í ¼ººÐ(»óó°¡ ³µÀ» ¶§ ÃâÇ÷ÀÌ ¸ÜÀ» ¼ö ÀÖµµ·Ï ÇÔ) µîÀÌ Æ÷ÇԵȴÙ.
¿µ¹® plasma membrane ÇÑ±Û ÇüÁú¸·
¼³¸í   
  ¿øÇüÁú Ç¥¸éÀ» µ¤´Â ¿¯Àº¸·. µÎ²²´Â 5~25¥ìmÀÌ´Ù. ±¤ÇÐÇö¹Ì°æÀ¸·Î´Â °üÂûÇÒ ¼ö ¾øÁö¸¸ ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂûÀÌ °¡´ÉÇÏ´Ù. ¿øÇüÁú¸·ÀÇ ºÐÀÚ±¸Á¶´Â ·¹½ÃƾÀ̳ª ÄÝ·¹½ºÅ×·Ñ µîÀǠǥ¸é È°¼º¹°Áú ºÐÀÚ°¡ 2ºÐÀÚÃþÀ¸·Î ±× Ç¥¸é¿¡ ¹è¿­µÇ¸ç, À̰ÍÀ» °¢ 1ºÐÀÚÃþÀÇ ´Ü¹éÁú ºÐÀÚ°¡ ¾çÂÊ¿¡¼­ »÷µåÀ§Ä¡ÇÑ ´ÜÀ§¸· ±¸Á¶ÀÌ´Ù. ÀüÀÚÇö¹Ì°æÀûÀ¸·Î ÀÌ ´ÜÀ§´Â ¾Ï-¸í-¾ÏÀÇ 3Ãþ(°¢ ¾à 20nm)À¸·Î ±¸º°µÈ´Ù. ¿øÇüÁúÀÇ Åõ°ú¼º¿¡ Áß¿äÇÑ ±¸½ÇÀ» Çϸç, »ý¸®»óŰ¡ º¯Çϸ頱נÅõ°ú¼ºµµ ½Å¼ÓÈ÷ º¯ÇÑ´Ù. ¶Ç, ¼Õ»óÀÌ µÇ¸é ½±°Ô »õ·Î Çü¼ºµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • human plasma protein fraction
    »ç¶÷Ç÷Àå´Ü¹éºÐÀ²
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antihemophilic human plasma
    Ç×Ç÷¿ìº´Ç÷Àå
  • normal human plasma
    Á¤»ó»ç¶÷Ç÷Àå
  • attributable fraction
    ±â¿©ºÐÀ²
  • absorbed fraction
    Èí¼öºÐÀ²
  • ejection fraction
    ¹ÚÃâ·ü, ¹ÚÃâºÐÀ²
  • etiologic fraction
    ¿øÀκÐÀ²
  • filtration fraction
    ¿©°úºÐÀ², °Å¸£±âºÐÀ²
  • fraction
    1. ºÐ¼ö, ºÐÀ² 2. ºÎºÐ 3. ºÐȹ, ºÐÇÒ
  • fraction of inspired oxygen
    ÈíÀÔ»ê¼Ò³óµµ
  • growth fraction
    ¼ºÀåºÐÀ²
  • hypoxic fraction
    Àú»ê¼ÒºÐȹ
  • inspired oxygen fraction
    µé¼û»ê¼ÒºÐÀ², Èí±â»ê¼ÒºÐÀ²
  • mole fraction
    ¸ôºÐÀ²
  • motor unit fraction
    ¿îµ¿´ÜÀ§ºÐȹ
  • oxygen fraction in inspired air
    ÈíÀÔ»ê¼Ò³óµµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fraction in inspired oxygen
    ÈíÀÔ»ê¼Ò³óµµ
  • fraction
    ºÎºÐ, ºÐÀ², ºÐȹ
  • ejection fraction
    ¹ÚÃâ°è¼ö, ¹ÚÃâÀ²
  • oxygen fraction in inspired air
    ÈíÀÔ»ê¼Ò³óµµ
  • human experiment
    ÀÎü½ÇÇè
  • human menopausal gonadotropin
    »ç¶÷Æó°æ»ý½Ä»ùÀÚ±ØÈ£¸£¸ó
  • human
    »ç¶÷, Àΰ£
  • human papilloma virus test
    »ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º°Ë»ç
  • human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • human papilloma virus
    »ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º
  • protein binding
    ´Ü¹é°áÇÕ
  • plasma cell
    ÇüÁú¼¼Æ÷
  • plasma expander
    Ç÷ÀåÁõ·®Á¦
  • plasma exchange
    Ç÷À屳ȯ(¼ú)
  • plasma volume expander
    ÀΰøÇ÷ÀåÁõ·®Á¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • stable plasma protein solution
    ¾ÈÁ¤Ç÷Àå´Ü¹é¿ë¾×
  • absorbed fraction
    Èí¼öºÐÀ²
  • attributable fraction
    ±â¿©ºÐÀ²
  • fraction collector
    ºÐȹ¼öÁý±â
  • ejection fraction
    ¹ÚÃâ°è¼ö, ¹ÚÃâÀ²
  • etiologic fraction
    ¿øÀκÐÀ²
  • fraction
    ºÎºÐ, ºÐÀ², ºÐȹ
  • filtration fraction
    °Å¸£±âºÐÀ², ¿©°úºÐÀ²
  • growth fraction
    ¼ºÀåºÐÀ²
  • hypoxic fraction
    Àú»ê¼ÒºÐȹ
  • inspired oxygen fraction
    Èí±â»ê¼ÒºÐÀ²
  • mole fraction
    ¸ôºÐÀ²
  • motor unit fraction
    ¿îµ¿´ÜÀ§ºÐȹ
  • volume fraction
    ºÎÇǺÐÀ², ¿ëÀûºÐÀ²
  • tubular rejection fraction ratio
    ÄáÆÏ´¢¼¼°ü°ÅºÎºÐȹ·ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • plasma protein fraction =PCC
    Ç÷Àå´Ü¹éºÐȹ
  • plasma protein
    Ç÷Àå´Ü¹éÁú(úìíìÓ±ÛÜòõ).
  • plasma protein
    Ç÷Àå´Ü¹é(Áú)
  • plasma protein binding
    Ç÷Àå´Ü¹é°áÇÕ.
  • Filtration fraction
    ¿©°úºÐÀ²(¡­ÝÂëÒ)
  • Miettinen etiologic fraction
    ¹Ì¿¡Æ¼³Ùº´ÀκÐȹ
  • absorbed fraction
    Èí¼öºÐÀ²
  • fraction
    ºÐȹ(ÝÂüñ), ºÐÀ²(ÝÂëÒ).
  • fraction
    ºÐȹ
  • fraction size
    ºÐÇÒ¼±·®
  • growth fraction
    Áõ½ÄºÐȹ
  • hypoxic fraction
    Àú»ê¼ÒºÐȹ
  • inspired oxygen fraction
    Èí±â»ê¼ÒºÐÀ²
  • recombination fraction
    ÀçÁ¶Çպмö(î¢ðàùêÝÂâ¦)
  • reducible fraction
    ¹Ì¾àºÐ¼ö(Ú±å³ÝÂâ¦).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • plasma protein fraction =PCC
    Ç÷Àå´Ü¹éºÐȹ
  • citrated normal human plasma
    Á¤»óÀα¸¿¬»ê¿°Ã·°¡Ç÷Àå.
  • plasma cell orificial mucositis => plasma cell cheilitis
  • plasma protein
    Ç÷Àå´Ü¹é(Áú)
  • plasma protein
    Ç÷Àå´Ü¹éÁú(úìíìÓ±ÛÜòõ).
  • plasma protein binding
    Ç÷Àå´Ü¹é°áÇÕ.
  • stable plasma protein solution =SPPS
    ¾ÈÁ¤Ç÷Àå(´Ü¹é)¿ë¾×(¡­úìíìÓ±ÛÜéÁ äû).
  • tidal plasma protein
    ¼øÈ¯Ç÷Àå´Ü¹é·®(âàü»úìíìÓ±ÛÜåÖ).
  • absorbed fraction
    Èí¼öºÐÀ²
  • early labeled fraction
    Á¶±âÇ¥ÁöºÐȹ(¡­øöãÛÝÂüñ).
  • ejection fraction
    ¹ÚÃâ°è¼ö.
  • ejection fraction
    ¹ÚÃâÀ² (ÚÑõó×Ë)
  • ejection fraction
    ¹ÚÃâ°è¼ö(ÚÑõóÌõâ¦).
  • ejection fraction
    ±¸ÃâÀ²
  • etiologic fraction
    ¿øÀÎÀû ¿ä¼Ò
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Protein granule
    ´Ü¹éÁú°ú¸³
    [¿¾ ¿ë¾î] ´Ü¹éÁú°ú¸³
  • Human placenta
    »ç¶÷ŹÝ
    [¿¾ ¿ë¾î] ÀÎŹÝ
  • Lymph plasma
    ¸²ÇÁÀå¾×
    [¿¾ ¿ë¾î] ÀÓÆÄÀå¾×
  • Plasma membrane of erythrocyte
    ÀûÇ÷±¸ÇüÁú¸·
    [¿¾ ¿ë¾î] ÀûÇ÷±¸ÇüÁú¸·
  • Blood plasma
    Ç÷Àå
    [¿¾ ¿ë¾î] Ç÷Àå
  • Plasma membrane
    ÇüÁú¸·
    [¿¾ ¿ë¾î] ¼¼Æ÷¸·
  • Plasma cell
    ÇüÁú¼¼Æ÷
    [¿¾ ¿ë¾î] ÇüÁú¼¼Æ÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • interstitial plasma cell pneumonia
    °£Áú¼ºÇüÁú¼¼Æ÷Æó¿°
  • human flea(=Pulex irritans)
    »ç¶÷º­·è
  • human parasitology
    ÀÎü±â»ýÃæÇÐ
  • adherence protein
    ºÎÂø´Ü¹éÁú
  • circumsporozoite protein (CSP)
    Æ÷ÀÚ¼Òü¸·´Ü¹éÁú
  • protein layer
    ´Ü¹éÁúÃþ
  • stage-specific protein
    ¹ßÀ°´Ü°èƯÀ̴ܹéÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • human chorionic gonadotropin
    ÀÎü À¶¸ð¼º ¼º¼± ÀÚ±Ø(ìÑô÷ëÖÙ¾àõàõàÊí©Ð½) È£¸£¸ó
  • human lactogen
    ÀÎü(ìÑô÷) ¶ôÅäÀü
  • sex steroid binding plasma protein
    ¼º(àõ)½ºÅ×·ÎÀÌµå °áÇÕ(Ì¿ùê) Ç÷Àå(úìíì) ´Ü¹éÁú(úìíìÓ±ÛÜòõ)
  • alpha fraction
    ¾ËÆÄºÐȹ(ÝÂüñ)
  • antibody binding fraction
    Ç×ü°áÇÕºÐȹ (ù÷ô÷Ì¿ùêÝÂüò)
  • beta fraction
    º£Å¸ ºÐȹ(ÝÂüñ)
  • Cohn fraction
    ÄÜ ºÐȹ(ÝÂüñ)
  • filtration fraction
    ¿©°ú(ÕëΦ) ºÐȹ(ÝÂüñ)
  • fraction
    "ºÐȹ(ÝÂüñ), ºÐÀ²(ÝÂëÒ)"
  • fraction-antibody binding
    ºÎºÐÇ×ü °áÇÕ(Ý»ÝÂù÷ô÷Ì¿ùê)
  • fraction collector
    ºÐȹ ¼öÁý±â(ÝÂüñâ¥ó¢Ðï)
  • low-density fraction
    Àú¹ÐµµºÐȹ(î¸ÚËÓøÝÂüñ)
  • mole fraction
    ¸ô ºÐȹ(ÝÂüñ)
  • omega fraction
    ¿À¸Þ°¡ ºÐȹ(ÝÂüñ)
  • particulate fraction
    ÀÔÀÚ ºÐȹ(Ø£í­ÝÂüñ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • plasma protein
    Ç÷Àå´Ü¹éÁú
  • HLA[=human leukocyte antigen]
    HLAÇ׿ø, Àΰ£¹éÇ÷±¸Ç׿ø
  • ejection fraction
    ¹ÚÃâ°è¼ö
  • fraction
    ºÐȹ, ºÐÀ²
  • plasma
    Ç÷Àå, ÇöóÁ
  • plasma cell
    ÇüÁú¼¼Æ÷
  • plasma cell pneumonia
    ÇüÁú¼¼Æ÷¼ºÆó·Å
  • plasma expander
    ÇöóÁÁõ·®Á¦
  • plasma substitute
    Ç÷Àå´ë¿ëÁ¦
  • Bence-Jones protein
    º¥½º-Á¸½º´Ü¹é
  • C-reactive protein
    C-¹ÝÀÀ¼º´Ü¹éÁú
  • high protein diet
    °í´Ü¹é½ÄÀÌ
  • protein
    ´Ü¹é(Áú)
  • protein metabolism
    ´Ü¹é(Áú)´ë»ç
  • protein-losing enteropathy
    ´Ü¹é»ó½Ç¼ºÀ庴Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LP labile peptide; labile protein; laboratory procedure; lactic peroxidase; lamina propria; laryngophar...
PC avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell...
PP diphosphate group; emphysema [pink puffers]; near point of accommodation [Lat. punctum proximum]; pa...
PPF Plasma Protein Fraction
beta [Greek letter beta] an anomer of a carbohydrate; buffer capacity; carbon separated from a carboxyl by one other carbon i...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PPF Plasma Protein Fraction
Fraction 1 fraction
HSP Human seminal plasma
NHP normal human plasma
PPC Plasma Protein Concentration
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • citrated normal human plasma
    Á¤»óÀÎ ±¸¿¬»ê¿° ÷°¡ Ç÷Àå
  • pathologic plasma protein
    º´Àû Ç÷Àå ´Ü¹é
  • plasma protein
    Ç÷Àå ´Ü¹é, Ç÷Àå ´Ü¹éÁú
    1. Ç÷Àå¿¡ Á¸ÀçÇÏ´Â ¿©·¯ Á¾·ùÀÇ ´Ü¹éÁú. ¿î¹Ý ´Ü¹éÁú
  • plasma protein binding
    Ç÷Àå ´Ü¹é °áÇÕ
  • absorbed fraction
    Èí¼öºÐÀ²
  • ejection fraction
    ¹ÚÃâ °è¼ö
    ½É½Ç ÀÌ¿Ï ¸»±âÀÇ ½É½Ç Ç÷¾×·®¿¡ ´ëÇÑ 1ȸ ¹ÚÃâ·® ºñ¸¦ ¸»Çϸç, ¾ÈÁ¤½Ã ¾à 60%°¡ µÈ´Ù.
  • filtration fraction
    ¿©ÆÄºÐÀ²
  • fraction size
    ºÐÇÒ¼±·®
  • hypoxic fraction
    Àú»ê¼Ò ºÐȹ
  • liver isozyme fraction
    °£ È¿¼Ò À¯ºÐ
  • molar fraction
    ¸ôºÐÀ²
  • partial fraction
    ºÎºÐ ºÐ¼ö, ºÐȹ
  • serum cholesterol fraction
    Ç÷û ÄÝ·¹½ºÅ×·Ñ ºÐȹ
    Ç÷û Áß ÃÑÄÝ·¹½ºÅ×·ÑÀº Æò±Õ 200mg 100ml ¿¡½ºÅÍÈ­µÇÁö ¾ÊÀº À¯¸®ÇÑ ÄÝ·¹½ºÅ×·ÑÀº Æò±Õ 55mgÀÌ´Ù.
  • blood plasma substitute
    ´ë¿ë Ç÷Àå
  • malignant plasma cell
    ¾Ç¼º ÇüÁú ¼¼Æ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
human plasma protein fraction A sterile solution of selected proteins derived from the blood plasma of adult human donors, containing 4.5 to 5.5 g of protein per 100 ml, of which 83 to 90% is albumin and the remainder is alpha-and beta-globulins; used as a blood volume supporter.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
dried human plasma protein fraction Freeze-dried human plasma protein fraction.
(05 Mar 2000)
human antihemophilic fraction A lyophilised concentrate of factor VIII, obtained from fresh normal human plasma; used as a haemostatic agent in haemophilia.
Synonym: antihemophilic globulin, human antihemophilic fraction.
(05 Mar 2000)
fraction I protein <protein> See ribulose bisphosphate carboxylase/oxidase RUBISCO).
(18 Nov 1997)
normal human plasma Sterile plasma obtained by pooling approximately equal amounts of the liquid portion of citrated whole blood from eight or more adult humans who have been certified as free from any disease which is tranmissible by transfusion, and treating it with ultraviolet irradiation to destroy possible bacterial and viral contaminants.
(05 Mar 2000)
plasma protein <haematology> One of the hundreds of different proteins present in blood plasma, including carrier proteins (such albumin, transferrin and haptoglobin), fibrinogen and other coagulation factors, complement components, immunoglobulins, enzyme inhibitors, precursors of substances such as angiotension and bradykinin and many other types of proteins.
(14 Oct 1997)
pregnancy-associated alpha-plasma protein An alpha 2-macroglobulin, molecular weight approximately 750,000 now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during the second trimester and continue to rise until the end of gestation.
(12 Dec 1998)
pregnancy-associated beta-plasma protein A beta-globulin now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during pregnancy until the end of gestation.
(12 Dec 1998)
aetiological fraction <epidemiology> The reduction in disease when a risk factor is removed. If I* is the number of people that a risk factor is responsible for and I is the total number of cases over the same period, then the aetiological fraction is I*/I. Equivalently, the aetiological fraction is (I-Io)/I. Where Io is the number of cases in the absence of the risk factor. Also known as the attributable fraction.
(05 Dec 1998)
amorphous fraction of adrenal cortex Noncrystalline residue of an acetone extract of the adrenal cortex after crystalline steroids, e.g., corticosterone, deoxycorticosterone, etc., have been isolated.
(05 Mar 2000)
attributable fraction <epidemiology> The same as aetiological fraction.
(05 Dec 1998)
recombination fraction The proportion of progeny of a mating pair of specific genotype and coupling phase that are recombinant; there must be no differential selection among the possible types of progeny, and the recombination fraction should be the same regardless of the alleles involved or their coupling phase.
(05 Mar 2000)
regurgitant fraction The amount of blood regurgitated into a cardiac chamber divided by the stroke output; normally, no blood regurgitates; in patients with severe valvular lesions such as mitral or aortic insufficiency, regurgitation can approach 80%; this fraction affords a quantitative measure of the severity of the valvular lesion.
(05 Mar 2000)
microsomal fraction Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (glick, glossary of biochemistry and molecular biology, 1990; from rieger et al., glossary of genetics: classical and molecular, 5th ed)
(12 Dec 1998)
mole fraction The ratio of the moles of one component of a system to the total moles of all the components present.
(05 Mar 2000)
ejection fraction <cardiology> A measure of ventricular contractility, equal to normally 65
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 2 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÇöóÁÅ×ÀÎÁÖ250ml - »õâ
³ì½ÊÀÚ
A10200082 Human plasma protein fraction
Àü¹®ÀǾàǰ | »èÁ¦
ÇöóÁÅ×ÀÎÁÖ100ml - »õâ
³ì½ÊÀÚ
A10200081 Human plasma protein fraction
Àü¹®ÀǾàǰ | »èÁ¦
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • plasma
    ¿øÇüÁú;Ç÷Àå;Àӯľ×;À¯Àå
  • protein
    ´Ü¹éÁú
  • coat protein
    ÇǸ· ´Ü¹é
  • conjugated protein
    º¹ÇÕ ´Ü¹éÁú
  • fish protein concentrate
    ¾îÀ° ³óÃà ´Ü¹é
  • protein
    ´Ü¹éÁú;´Ü¹éÁúÀÇ(À» ÇÔÀ¯ÇÏ´Â). proteinic a.
  • protein clock
    ´Ü¹éÁú ½Ã°è(´Ü¹éÁú ÁøÈ­ ¼Óµµ¸¦ Á¶ÀýÇÏ´Â °¡¼³Àû ü³» ±â±¸)
  • repressor protein
    ¾ïÁ¦ ´Ü¹é(Á¦¾î À¯ÀüÀÚ¿¡ ÀÇÇÏ¿© ¸¸µé¾îÁö´Â ´Ü¹é)
  • fraction
    ¼Ò·®
  • common fraction
    »óºÐ¼ö
  • complex fraction
    º¹ºÐ¼ö
  • compound fraction
    COMPLEX FRACTION
  • continued fraction
    ¿¬ºÐ¼ö
  • decimal fraction
    ¼Ò¼ö
  • fraction
    ´ÜÆí;ºÎºÐ;ºÐ¼ö;ÆÄÆí;Á¶±Ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á